Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

VW Nitti; D Ginsberg; Karl-Dietrich Sievert; D Sussman; S Radomski; P Sand; D De Ridder; B Jenkins; A Magyar; C Chapple

doi:10.1016/j.juro.2016.03.146

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

VW Nitti, D Ginsberg, Karl-Dietrich Sievert (Co-author), D Sussman, S Radomski, P Sand, D De Ridder, B Jenkins, A Magyar, C Chapple

Department of Urology and Andrology

Research output: Contribution to journal › Original Article › peer-review

82 Citations (Web of Science)

Original language	English
Pages (from-to)	791-800
Journal	JOURNAL OF UROLOGY
Volume	196
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2016.03.146
Publication status	Published - 2016

Keywords

QUALITY-OF-LIFE
PLACEBO-CONTROLLED TRIAL
URINARY-INCONTINENCE
BOTULINUM-TOXIN
PERSISTENCE
SYMPTOMS

Access to Document

10.1016/j.juro.2016.03.146

Cite this

Nitti, VW., Ginsberg, D., Sievert, K.-D., Sussman, D., Radomski, S., Sand, P., De Ridder, D., Jenkins, B., Magyar, A., & Chapple, C. (2016). Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. JOURNAL OF UROLOGY , 196(3), 791-800. https://doi.org/10.1016/j.juro.2016.03.146

Nitti, VW ; Ginsberg, D ; Sievert, Karl-Dietrich et al. / Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. In: JOURNAL OF UROLOGY 2016 ; Vol. 196, No. 3. pp. 791-800.

@article{b04a9a2fdebd42918b5b5dac3c9a2651,

title = "Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study",

keywords = "QUALITY-OF-LIFE, PLACEBO-CONTROLLED TRIAL, URINARY-INCONTINENCE, BOTULINUM-TOXIN, PERSISTENCE, SYMPTOMS",

author = "VW Nitti and D Ginsberg and Karl-Dietrich Sievert and D Sussman and S Radomski and P Sand and {De Ridder}, D and B Jenkins and A Magyar and C Chapple",

note = "Sievert: Paracelsus Med Univ, Dept Urol *** Androl, Salzburg, Austria",

year = "2016",

doi = "10.1016/j.juro.2016.03.146",

language = "English",

volume = "196",

pages = "791--800",

journal = "JOURNAL OF UROLOGY ",

issn = "0022-5347",

publisher = "ELSEVIER SCIENCE INC",

number = "3",

}

Nitti, VW, Ginsberg, D, Sievert, K-D, Sussman, D, Radomski, S, Sand, P, De Ridder, D, Jenkins, B, Magyar, A & Chapple, C 2016, 'Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study', JOURNAL OF UROLOGY , vol. 196, no. 3, pp. 791-800. https://doi.org/10.1016/j.juro.2016.03.146

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. / Nitti, VW; Ginsberg, D; Sievert, Karl-Dietrich (Co-author) et al.
In: JOURNAL OF UROLOGY , Vol. 196, No. 3, 2016, p. 791-800.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

AU - Nitti, VW

AU - Ginsberg, D

AU - Sievert, Karl-Dietrich

AU - Sussman, D

AU - Radomski, S

AU - Sand, P

AU - De Ridder, D

AU - Jenkins, B

AU - Magyar, A

AU - Chapple, C

N1 - Sievert: Paracelsus Med Univ, Dept Urol *** Androl, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - QUALITY-OF-LIFE

KW - PLACEBO-CONTROLLED TRIAL

KW - URINARY-INCONTINENCE

KW - BOTULINUM-TOXIN

KW - PERSISTENCE

KW - SYMPTOMS

U2 - 10.1016/j.juro.2016.03.146

DO - 10.1016/j.juro.2016.03.146

M3 - Original Article

C2 - 27038769

SN - 0022-5347

VL - 196

SP - 791

EP - 800

JO - JOURNAL OF UROLOGY

JF - JOURNAL OF UROLOGY

IS - 3

ER -

Nitti VW, Ginsberg D, Sievert KD, Sussman D, Radomski S, Sand P et al. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. JOURNAL OF UROLOGY . 2016;196(3):791-800. doi: 10.1016/j.juro.2016.03.146